These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11764011)

  • 1. Influence of antidepressant pharmacotherapy on behavioral treatment adherence and smoking cessation outcome in a combined treatment involving fluoxetine.
    Hitsman B; Spring B; Borrelli B; Niaura R; Papandonatos GD
    Exp Clin Psychopharmacol; 2001 Nov; 9(4):355-62. PubMed ID: 11764011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of sequential use of fluoxetine for smoking cessation in elevated depressive symptom smokers.
    Brown RA; Abrantes AM; Strong DR; Niaura R; Kahler CW; Miller IW; Price LH
    Nicotine Tob Res; 2014 Feb; 16(2):197-207. PubMed ID: 24057928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant pharmacotherapy helps some cigarette smokers more than others.
    Hitsman B; Pingitore R; Spring B; Mahableshwarkar A; Mizes JS; Segraves KA; Kristeller JL; Xu W
    J Consult Clin Psychol; 1999 Aug; 67(4):547-54. PubMed ID: 10450625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial.
    Cook JW; Spring B; McChargue DE; Borrelli B; Hitsman B; Niaura R; Keuthen NJ; Kristeller J
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):153-9. PubMed ID: 14727000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of fluoxetine combined with nicotine inhalers in smoking cessation--a randomized trial.
    Blondal T; Gudmundsson LJ; Tomasson K; Jonsdottir D; Hilmarsdottir H; Kristjansson F; Nilsson F; Bjornsdottir US
    Addiction; 1999 Jul; 94(7):1007-15. PubMed ID: 10707439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment.
    Niaura R; Spring B; Borrelli B; Hedeker D; Goldstein MG; Keuthen N; DePue J; Kristeller J; Ockene J; Prochazka A; Chiles JA; Abrams DB
    J Consult Clin Psychol; 2002 Aug; 70(4):887-96. PubMed ID: 12182272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influences of gender and weight gain on short-term relapse to smoking in a cessation trial.
    Borrelli B; Spring B; Niaura R; Hitsman B; Papandonatos G
    J Consult Clin Psychol; 2001 Jun; 69(3):511-5. PubMed ID: 11495180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking cessation interventions for smokers with current or past depression.
    van der Meer RM; Willemsen MC; Smit F; Cuijpers P
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bupropion and cognitive-behavioral treatment for depression in smoking cessation.
    Brown RA; Niaura R; Lloyd-Richardson EE; Strong DR; Kahler CW; Abrantes AM; Abrams D; Miller IW
    Nicotine Tob Res; 2007 Jul; 9(7):721-30. PubMed ID: 17577801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial.
    Rabin RA; Ashare RL; Schnoll RA; Cinciripini PM; Hawk LW; Lerman C; Tyndale RF; George TP
    Am J Addict; 2016 Jun; 25(4):291-6. PubMed ID: 27187893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimenter-defined quit dates for smoking cessation: adherence improves outcomes for women but not for men.
    Borrelli B; Papandonatos G; Spring B; Hitsman B; Niaura R
    Addiction; 2004 Mar; 99(3):378-85. PubMed ID: 14982551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind fluoxetine in depressed alcoholic smokers.
    Cornelius JR; Salloum IM; Ehler JG; Jarrett PJ; Cornelius MD; Black A; Perel JM; Thase ME
    Psychopharmacol Bull; 1997; 33(1):165-70. PubMed ID: 9133770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial.
    Coppen A; Bailey J
    J Affect Disord; 2000 Nov; 60(2):121-30. PubMed ID: 10967371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting smoking cessation. Who will quit with and without the nicotine patch.
    Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB
    JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
    Lam RW; Levitt AJ; Levitan RD; Michalak EE; Cheung AH; Morehouse R; Ramasubbu R; Yatham LN; Tam EM
    JAMA Psychiatry; 2016 Jan; 73(1):56-63. PubMed ID: 26580307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?
    Koran LM; Cain JW; Dominguez RA; Rush AJ; Thiemann S
    Am J Psychiatry; 1996 Nov; 153(11):1450-4. PubMed ID: 8890679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of adherence to pharmacological and behavioral treatment in a cessation trial among smokers in Aleppo, Syria.
    Ben Taleb Z; Ward KD; Asfar T; Bahelah R; Maziak W
    Drug Alcohol Depend; 2015 Aug; 153():167-72. PubMed ID: 26077603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.